Morgan Stanley Astrazeneca PLC Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Astrazeneca PLC stock. As of the latest transaction made, Morgan Stanley holds 15,768,536 shares of AZN stock, worth $1.16 Billion. This represents 0.09% of its overall portfolio holdings.

Number of Shares

15,768,536

Previous 17,301,089 8.86%

Holding current value

$1.16 Billion

Previous $1.13 Billion 2.24%

% of portfolio

0.09%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $100 Million - $119 Million	-1,532,553 Reduced 8.86%	15,768,536 $1.16 Billion
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $283 Million - $356 Million	4,476,178 Added 34.9%	17,301,089 $1.13 Billion
Q3 2024 May 14, 2025	BUY	$76.67 - $87.62 $32.6 Million - $37.2 Million	424,600 Added 3.42%	12,824,911 $999 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $32.6 Million - $37.2 Million	424,600 Added 3.42%	12,824,911 $999 Million
Q2 2024 May 14, 2025	SELL	$66.81 - $80.83 $327 Million - $396 Million	-4,900,778 Reduced 28.33%	12,400,311 $967 Million
Q2 2024 Oct 17, 2024	SELL	$66.81 - $80.83 $180 Million - $218 Million	-2,700,836 Reduced 17.88%	12,400,311 $967 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $180 Million - $218 Million	-2,700,836 Reduced 17.88%	12,400,311 $967 Million
Q1 2024 Oct 17, 2024	BUY	$61.03 - $69.57 $165 Million - $188 Million	2,700,836 Added 21.78%	15,101,147 $1.02 Billion
Q1 2024 Aug 16, 2024	BUY	$61.03 - $69.57 $157 Million - $179 Million	2,570,987 Added 20.52%	15,101,147 $1.02 Billion
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $157 Million - $179 Million	2,570,987 Added 20.52%	15,101,147 $1.02 Billion
Q4 2023 Aug 16, 2024	BUY	$61.89 - $69.28 $8.04 Million - $9 Million	129,849 Added 1.05%	12,530,160 $844 Million
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $45.3 Million - $50.7 Million	-731,545 Reduced 5.52%	12,530,160 $844 Million
Q3 2023 Nov 15, 2023	SELL	$64.85 - $71.7 $15.8 Million - $17.5 Million	-244,056 Reduced 1.81%	13,261,705 $898 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $38.7 Million - $42 Million	553,713 Added 4.28%	13,505,761 $967 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $172 Million - $195 Million	2,729,451 Added 26.7%	12,952,048 $899 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $84.6 Million - $110 Million	1,561,194 Added 18.02%	10,222,597 $693 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $14.5 Million - $37.2 Million	273,794 Added 3.26%	8,661,403 $475 Million
Q2 2022 Oct 27, 2022	BUY	$59.26 - $71.14 $313 Million - $376 Million	5,284,956 Added 170.34%	8,387,609 $554 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $313 Million - $376 Million	5,284,956 Added 170.34%	8,387,609 $554 Million
Q1 2022 Oct 27, 2022	SELL	$55.72 - $67.12 $294 Million - $355 Million	-5,284,956 Reduced 63.01%	3,102,653 $206 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $4.43 Million - $5.34 Million	-79,580 Reduced 2.5%	3,102,653 $206 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $67.1 Million - $79.3 Million	-1,242,918 Reduced 28.09%	3,182,233 $185 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $246 Million - $269 Million	4,425,151 New	4,425,151 $266 Million

Others Institutions Holding AZN

# of Institutions

1,433

Shares Held

507M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account